SPONSOR
JSC NextGen
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3, Phase 3
Conditions studied: ICInterstitial Cystitis and Bladder Pain SyndromeInterstitial Cystitis, ChronicUlcer FootMellitus Diabetes
JSC NextGen is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including IC, Interstitial Cystitis and Bladder Pain Syndrome, Interstitial Cystitis, Chronic, Ulcer Foot.
The trial portfolio spans Phase 2, Phase 3, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — JSC NextGen
How many clinical trials has JSC NextGen sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by JSC NextGen, of which 2 are actively recruiting participants. These trials cover conditions including IC, Interstitial Cystitis and Bladder Pain Syndrome, Interstitial Cystitis, Chronic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does JSC NextGen research focus on?
JSC NextGen clinical trials span IC, Interstitial Cystitis and Bladder Pain Syndrome, Interstitial Cystitis, Chronic, Ulcer Foot, Mellitus Diabetes. The research pipeline includes Phase 2, Phase 3, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a JSC NextGen clinical trial?
To participate in a JSC NextGen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all JSC NextGen trials with current recruitment status updated daily.
Clinical Trials by JSC NextGen
NCT07391306 Phase 2, Phase 3
Recruiting
The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.
IC
NCT07391319 Phase 3
Recruiting
The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial
Ulcer Foot
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology